Evernow Review

Evernow: a women's menopause clinic that also does branded GLP-1s

Evernow is not really a weight-loss startup that happens to treat women. It's the other way around: a women's-health telehealth platform built around menopause and hormone replacement therapy (HRT), with GLP-1 weight loss bolted on as one more symptom vertical. That framing matters, because it changes who this is genuinely a good fit for. If you're a woman in or near menopause who wants weight management handled by the same clinician thinking about your hot flashes, sleep, and hormones, Evernow is one of the few places that treats those as a single conversation. If you just want the cheapest fast track to a GLP-1, this isn't it.

Branded first — Ozempic, Wegovy, Zepbound, Mounjaro

This is Evernow's clearest differentiator from the flood of compounding-pharmacy telehealth brands. Evernow prescribes FDA-approved, brand-name medication: semaglutide as Ozempic and Wegovy, and tirzepatide as Zepbound and Mounjaro. Its prescription catalog lists the brand-name products, made by Novo Nordisk and Eli Lilly, that a doctor's office would write, although its Ozempic page also mentions compounded versions of GLP-1 medications, so ask your clinician which product you'd receive. For a lot of women that's the whole point — branded medication carries fewer of the sourcing and quality questions that hang over compounded GLP-1s.

How the money actually works

Evernow's pricing is deliberately two separate things, and it's worth understanding the split before you sign up. The membership covers care access — unlimited clinician messaging, prescriptions, and a personalized plan — and it costs $49 a month month to month, or $35 a month on the 12-month prepay. That fee is for the relationship with the clinic, not for the drug.

The medication itself is a different bill entirely, and this is where Evernow diverges from cash-pay competitors. The company is now accepting insurance for video visits, listing Blue Cross Blue Shield, Anthem, UnitedHealthcare, and Aetna. So the cost of your Ozempic or Zepbound depends on your plan's coverage and your pharmacy copay. It could be a manageable copay if your insurer covers GLP-1s, or it could be the brand's full list price (well over a thousand dollars a month) if they don't. Evernow does not post a flat cash medication price, which is honest but means you can't price-shop it the way you can a compounded provider charging a fixed monthly rate. For context, the typical monthly cost sits around $179, but that number doesn't really apply to an insurance-routed model like this one.

How we get the category median: $179 is the middle value of the cheapest ongoing monthly price (not a first-month promo) at each of the 515 GLP-1 providers we track.

What you should confirm before paying

• Whether your specific insurance plan covers branded GLP-1s for weight loss — coverage varies wildly even within BCBS or Aetna
• Your expected pharmacy copay, since that, not the membership fee, is the real cost driver
• How cancellation and refunds work for the membership — Evernow doesn't publish a policy, so ask before you prepay

The real reason to choose Evernow: GLP-1 and HRT under one roof

The genuine standout here is integration. Weight gain, metabolic change, and appetite shifts often arrive at the same life stage as perimenopause and menopause, and most weight-loss telehealth platforms treat the GLP-1 in isolation. Evernow positions GLP-1 care as complementary to HRT, with the same clinicians and 24/7 messaging covering both. For a woman who is already managing menopause symptoms and wants the weight-loss medication coordinated against her hormone therapy rather than prescribed by a separate, unaware service, that coordinated model is hard to find elsewhere. You can do a one-time visit or the ongoing membership, so you're not forced into a subscription to get started.

Who should skip it

Be honest with yourself about fit. Skip Evernow if you're a man, or a woman who isn't dealing with menopause or hormone questions — you'd be paying for a menopause-built platform to handle a single weight-loss need, and a dedicated GLP-1 provider will be more direct. Skip it if you have no GLP-1 insurance coverage and want a predictable cash price, because the insurance-dependent model leaves your medication cost unknowable up front. Availability, at least, isn't a hurdle: Evernow says it serves all 50 states plus D.C.

Trust and medical oversight

On the safety dimensions that matter most, Evernow looks solid. Prescriptions come from US-licensed clinicians, the catalog lists FDA-approved branded products (its Ozempic page also mentions compounded versions, so confirm what you'd receive), and there are no FDA warning letters or enforcement actions on file for the company. Routing through insurance and real pharmacies adds another layer of conventional oversight. The honest caveats are about transparency, not safety: no posted medication price and no published cancellation or refund policy for the membership. Those are inconvenience and homework items, not red flags. You can see how we weigh branded sourcing, oversight, and disclosure in our scoring methodology.

Bottom line

Evernow is a strong, narrow recommendation. For women who want FDA-approved branded GLP-1 weight loss managed alongside menopause and HRT care, ideally with insurance coverage to absorb the medication cost, it's one of the more thoughtful options out there. The branded-first, insurance-accepting approach is a real advantage over compounding-first competitors. For everyone else, the menopause-centric design and unposted, insurance-dependent pricing make it the wrong tool. Know which of those you are before you book, confirm your coverage, and it can be an excellent fit.

If you're weighing alternatives, Collective ($59/month) is one of the closest options we track to Evernow.